Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Clinical trial NCT01074047 · COMPLETED

Trial details

NCT number: NCT01074047
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2010-06-01
Primary completion: 2014-01-22
Enrollment: 488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.